Results 81 to 90 of about 9,484 (203)

Efficacy and safety of carteolol long-acting solution 2% compared with timolol gel-forming solution 0.5% in patients with primary open-angle glaucoma and ocular hypertension: A randomized, parallel-group, open-label phase IV study in Taiwan

Journal of Medical Sciences, 2014
Purpose: The purpose of this study is to compare the efficacy and safety of 2% long-acting carteolol solution with 0.5% timolol gel-forming solution added to primary treatment of 0.005% latanoprost solution in patients with primary open-angle glaucoma ...
Hsin-Yu Yao, Yi-Hao Chen, Ming-Cheng Tai, Da-Wen Lu   +3 more
doaj   +1 more source

Magnetic Resonance Imaging of Optic Nerve Traction During Adduction in Primary Open-Angle Glaucoma With Normal Intraocular Pressure. [PDF]

, 2017
PurposeWe used magnetic resonance imaging (MRI) to ascertain effects of optic nerve (ON) traction in adduction, a phenomenon proposed as neuropathic in primary open-angle glaucoma (POAG).MethodsSeventeen patients with POAG and maximal IOP ≤ 20 mm Hg, and
Bonelli, Laura, Caprioli, Joseph, Clark, Robert A, Coleman, Anne L, Demer, Joseph L, Giaconi, JoAnn A, Law, Simon K, Nouri-Mahdavi, Kouros, Suh, Soh Youn   +8 more
core   +1 more source

Immunologic Corneal Graft Rejection after Administration of Topical Latanoprost: a Report of Two Patients

Journal of Ophthalmic & Vision Research, 2011
Purpose: To report endothelial corneal graft rejection after administration of topical latanoprost eye drops. Case Report: Two eyes of two patients with a history of multiple intraocular procedures prior to penetrating keratoplasty developed endothelial
Kouros Nouri-Mahdavi, Mohammad-Ali Javadi, Mohammad-Reza Jafarinasab   +2 more
doaj  

Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy [PDF]

, 2010
BACKGROUND:Prior research has demonstrated that medication persistence (continued acquisition of therapy over time) is far from optimal among patients with glaucoma.
Gail F Schwartz, Gregory Reardon, Sameer Kotak   +2 more
core   +2 more sources

Efficacy of selective laser trabeculoplasty versus latanoprost as initial management in glaucoma

Revista Brasileira de Oftalmologia
Objective: To compare the hypotensive effect of SLT vs the use of latanoprost in the initial management of patients with suspected glaucoma and diagnosis of glaucoma.
Oscar Luis Teheran Forero, Ruben Dario Neira Medina, Enrique Carlos Ramos Clason, Margarita María Ochoa-Díaz   +3 more
doaj   +1 more source

Open-Label Extension Study Comparing Latanoprost 0.005% Without vs With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension

Clinical Ophthalmology, 2022
Bridgitte Shen Lee,1 Ranjan Malhotra,2 Kenneth Sall,3 Brittany Mitchell,4 James Peace5 1Vision Optique, Houston, TX, USA; 2Ophthalmology Associates, St. Louis, MO, USA; 3Sall Research Medical Center, Inc., Artesia, CA, USA; 4Medical Affairs North America,
Shen Lee B, Malhotra R, Sall K, Mitchell B, Peace J   +4 more
doaj  

A Patient with Corneal Epithelial Disorder That Developed after Administration of a Latanoprost Generic, but Not a Brand-Name Drug, Eye Drop

Case Reports in Ophthalmological Medicine, 2012
Background. We report a patient who developed corneal epithelial disorder repeatedly after changing the prescription from Xalatan eye drops (Pfizer Inc.) to Latanoprost eye drops (Kaken Pharmaceutical Co., Ltd.), both containing 0.005% latanoprost. Case
Yukihisa Takada, Yuka Okada, Norihito Fujita, Shizuya Saika   +3 more
doaj   +1 more source

Glaucoma: Hot topics in Pharmacology [PDF]

, 2017
BACKGROUND: Glaucoma comprises a group of neurodegenerative diseases resulting in retinal ganglion cell death within the optic nerve head. It is projected to affect almost 80 million people worldwide by 2020.
Balendra, SI, Cordeiro, MF, Grzybowski, A, Jain, M, Shah, PA   +4 more
core   +1 more source

Latanoprost in the treatment of glaucoma

Clinical Ophthalmology, 2014
Albert AlmDepartment of Neuroscience, Ophthalmology, University Hospital, Uppsala, SwedenAbstract: Prostaglandins are approved by the European Glaucoma Society guidelines as first-line treatment for glaucoma.
Alm A
doaj  

Increasing healthcare costs: can we influence the costs of glaucoma care? [PDF]

, 2017
PURPOSE OF REVIEW Despite a decrease in real average growth rates per capita since 2009, healthcare costs continue to rise worldwide. Numerous patient-related and doctor-related factors have contributed to this rise.
Berlin, Michael S, Meier-Gibbons, Frances, Töteberg-Harms, Marc   +2 more
core   +1 more source